Warning
Bionpharma Inc. Recalls Divalproex Sodium Delayed-Release Tablets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0742-2026Drug / Pharmaceutical
Bionpharma Inc. Recalls Divalproex Sodium Delayed-Release Tablets
Bionpharma Inc. · Class II — Moderate Risk
Product Description
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Reason for Recall
Presence of Foreign Tablets/Capsules
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Bionpharma Inc. has recalled a pharmaceutical product that the FDA classified as Class II. The recall was initiated on June 26, 2026. Presence of Foreign Tablets/Capsules. It was distributed in US Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.